Concepedia

Katie Flaherty

KF

9

Publications

803

Citations

9

H-Index

2017

Active since

Affiliations

University of Nottingham(Current)

Nottingham University Hospitals NHS Trust

University of Edinburgh

University of Leicester

National University of Malaysia

Katie Flaherty is an author at University of Nottingham specializing in pharmacotherapy, cerebrovascular disease, and neurology.

ORCID

Top concepts

Publications per year

2017–2021

9

Publications

9

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Nikola Sprigg, Katie Flaherty, Jason P. Appleton et al. · The Lancet · 2018 · 462 citations · Full text

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 176 citations · Full text

Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial

Gordon W. Blair, Jason P. Appleton, Katie Flaherty et al. · EClinicalMedicine · 2019 · 49 citations · Full text

, , +15

Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT

Nikola Sprigg, Katie Flaherty, Jason P. Appleton et al. · Health Technology Assessment · 2019 · 28 citations · Full text

Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign

Christian Ovesen, Janus Christian Jakobsen, Christian Gluud et al. · Stroke · 2021 · 25 citations · Full text

Rows per page

1–5 of 9